How Expanscience works with healthcare professionals
Laboratoires Expanscience is supported by the expertise of healthcare professionals. They help us to meet patients' requirements, guarantee the safety and efficacy of our products and support scientific progress. We mainly call upon them for three reasons.
- Get the experts involved right from the early stages of a product's development
Healthcare professionals help us perform vital clinical trials when assessing the safety and efficacy of our products. These experts are involved in identifying the therapeutic needs, protocols and patients concerned. Throughout these trials, they monitor the patients. They are also involved in publishing the results.
We may also sometimes be required to support researchers by subsidising their work in the various therapeutic areas in which we operate. Working with healthcare professionals in this way enables them to work with real medicines or pharmaceutical specialities, and to expand their knowledge of diseases and of patients' needs.
- Get expert advice from healthcare professionals
When we want to share information with doctors, pharmacists or patients, we involve healthcare professionals who have been recruited for their expertise in our discussions. The aim is to tailor our information to meet the needs of the target that we want to reach. The doctors we consult also ensure that patients' interests are properly represented in our strategies. Their approval is also confirmation that our publications are reliable.
- Showcase their expertise at conferences, symposiums or roundtables
At events attended by bodies involved in healthcare, we try and get healthcare professionals to present the results of our research, or our new products, etc. In such cases, we make it clear if there is any conflict of interest that links us to the healthcare professional in question before they say anything. What they say is based on scientific data and is in compliance with current regulations in the country in question.
In France, our collaborations with healthcare professionals are governed by the Conseil National de l’Ordre des Médecins (France's National Medical Council), the Conseil National de l’Ordre des Pharmaciens (France's National Pharmacists’ Council), the DMOS law1 and the Bertrand Act, as well as regulations formulated by the ANSM2 and the DGS3. These contributions are covered in agreements in which the terms of our collaboration are detailed. The remuneration that healthcare professionals receive is in compliance with directives which govern the way in which the market value of their contributions is calculated. This is based on the healthcare professionals' specific obligations and the time required for them to perform the service requested. For example, a doctor who is required for a whole day will be paid on the basis of how much they earn for one day of consultations. And – in compliance with legislation – the details of travel expenses or meals enjoyed by these healthcare professionals within the framework of their work with us will be made public as soon as they exceed €10, including VAT.
1. DMOS law: Law no.93-121 1993 on Diverses Mesures d'Ordre Social – a French law concerning the financial benefits offered to physicians by the pharmaceutical industry
2. ANSM: Agence Nationale de Sécurité du Médicament, France’s national agency for the safety of medicines
3. DGS: France's Directorate-General for Health.